Chemical inhibitors of ICA69 can impact the protein's function through various biochemical pathways. Allopurinol, by inhibiting xanthine oxidase, reduces the production of reactive oxygen species (ROS), which can affect ICA69, as the protein is sensitive to oxidative stress. Reducing ROS production can indirectly inhibit oxidative damage to ICA69, preserving its functionality. Similarly, PD98059, as a specific inhibitor of MEK, disrupts the MAPK/ERK pathway, which is associated with ICA69 regulation. Through this inhibition, PD98059 can lead to a decrease in the functional activity of ICA69. LY294002, with its potent inhibition of PI3K, can disrupt the PI3K-Akt pathway, another signaling route crucial for ICA69 activity. By hindering this pathway, LY294002 can indirectly decrease ICA69 functionality. U73122, which inhibits phospholipase C, affects the IP3/DAG pathway that is vital for calcium release, and since ICA69 is regulated by calcium, this inhibition can indirectly reduce ICA69 activity.
In the second spectrum of inhibitors, SB203580 selectively targets p38 MAP kinase, a component of stress-activated MAPK signaling, which is pertinent to ICA69's role in cellular responses. By inhibiting p38, SB203580 can impede pathways involving ICA69, leading to its functional inhibition. Genistein, a tyrosine kinase inhibitor, can interrupt phosphorylation processes that regulate ICA69, leading to a decrease in its activity. The calcium chelator BAPTA-AM sequesters intracellular calcium, crucial for ICA69 function, thereby inhibiting it. KN-93, which inhibits Ca2+/calmodulin-dependent protein kinase II (CaMKII), affects calmodulin and calcium signaling, resulting in an indirect inhibition of ICA69. Chelerythrine and Gö 6983, both PKC inhibitors, can suppress the enzyme's activity in pathways that include ICA69, thus impeding the protein's function. Okadaic Acid, an inhibitor of protein phosphatases PP1 and PP2A, can alter the phosphorylation state of proteins within ICA69-related pathways, indirectly inhibiting ICA69. Lastly, W-7 antagonizes calmodulin, thereby influencing calcium signaling pathways that regulate ICA69, leading to its functional inhibition.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Allopurinol | 315-30-0 | sc-207272 | 25 g | $131.00 | ||
Allopurinol is an inhibitor of xanthine oxidase, an enzyme that generates reactive oxygen species (ROS). ICA69 is sensitive to oxidative stress; thus, by reducing ROS production, Allopurinol can indirectly inhibit oxidative damage to ICA69. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a specific inhibitor of MEK, which is part of the MAPK/ERK pathway. Since ICA69 function is regulated through pathways sensitive to MAPK/ERK signaling, PD98059's inhibition of this pathway can indirectly result in the functional inhibition of ICA69. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a potent inhibitor of PI3K, which participates in the signaling pathways that ICA69 is involved in. By inhibiting PI3K, LY294002 can disrupt the PI3K-Akt pathway, indirectly leading to the functional inhibition of ICA69. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 selectively inhibits p38 MAP kinase, a part of stress-activated MAPK signaling. The inhibition of this kinase can disrupt cellular responses in which ICA69 is involved, leading to its functional inhibition. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor and can inhibit various signal transduction pathways. ICA69 is regulated through phosphorylation by tyrosine kinases, and Genistein's inhibition can thus indirectly inhibit ICA69 function. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
BAPTA-AM is a cell-permeant calcium chelator, which can sequester intracellular calcium. As ICA69 is calcium-sensitive, the reduction in intracellular calcium levels by BAPTA-AM can inhibit the normal function of ICA69. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
KN-93 is an inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMKII). Since ICA69 is modulated by calmodulin and calcium signaling, KN-93's inhibition of CaMKII can indirectly lead to the functional inhibition of ICA69. | ||||||
Chelerythrine chloride | 3895-92-9 | sc-3547 sc-3547A | 5 mg 25 mg | $90.00 $317.00 | 17 | |
Chelerythrine is a potent inhibitor of Protein Kinase C (PKC), which is part of the signaling pathways that ICA69 is involved in. By inhibiting PKC, Chelerythrine can indirectly inhibit the function of ICA69. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Gö 6983 is a pan-PKC inhibitor, which, like Chelerythrine, can inhibit PKC involved in pathways with ICA69. The inhibition of PKC by Gö 6983 can result in the functional inhibition of ICA69. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases PP1 and PP2A. The inhibition of these phosphatases can alter the phosphorylation state of proteins in pathways involving ICA69, indirectly inhibiting its function. | ||||||